Cargando…
Ex Vivo Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell Carcinoma
The purpose of ex vivo drug screening in the context of precision oncology is to serve as a functional diagnostic method for therapy efficacy modeling directly on patient-derived tumor cells. Here, we report a case study using integrated multiomics ex vivo drug screening approach to assess therapy e...
Autores principales: | Nykänen, Noora, Mäkelä, Rami, Arjonen, Antti, Härmä, Ville, Lewandowski, Laura, Snowden, Eileen, Blaesius, Rainer, Jantunen, Ismo, Kuopio, Teijo, Kononen, Juha, Rantala, Juha K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481915/ https://www.ncbi.nlm.nih.gov/pubmed/34604070 http://dx.doi.org/10.3389/fonc.2021.735820 |
Ejemplares similares
-
Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma
por: Mäkelä, Rami, et al.
Publicado: (2020) -
Ex vivo assessment of targeted therapies in a rare metastatic epithelial–myoepithelial carcinoma
por: Mäkelä, Rami, et al.
Publicado: (2020) -
Ex vivo analysis of DNA repair targeting in extreme rare cutaneous apocrine sweat gland carcinoma
por: Mäkelä, Rami, et al.
Publicado: (2021) -
Blocking Activin Receptor Ligands Is Not Sufficient to Rescue Cancer-Associated Gut Microbiota—A Role for Gut Microbial Flagellin in Colorectal Cancer and Cachexia?
por: Pekkala, Satu, et al.
Publicado: (2019) -
Separase is a marker for prognosis and mitotic activity in breast cancer
por: Gurvits, Natalia, et al.
Publicado: (2017)